Healthcare analytics company based in United States
Surgisphere
Company type
Private
Industry
Healthcare analytics
Founded
2008[1]
Headquarters
Palatine, Illinois
,
US[2]
Key people
Sapan Desai (CEO and founder)
Number of employees
11
Website
surgisphere.com[dead link]
Surgisphere is an American healthcare analytics company established in 2008 by Sapan Desai. Originally a textbook marketing company, it came under scrutiny in May 2020 after it provided large datasets of COVID-19 patients that were subsequently found to be unreliable. The questionable data were used in studies published in The Lancet and The New England Journal of Medicine in May 2020, suggesting that COVID-19 patients on hydroxychloroquine had a "significantly higher risk of death". In light of these studies, the World Health Organization decided to temporarily halt global trials of the drug hydroxychloroquine to treat COVID-19. After the studies were retracted, the WHO trials were resumed and then discontinued shortly after.
^"Surgisphere Corp". Bloomberg. Retrieved 11 June 2020.
^Offord, Catherine (30 May 2020). "Disputed Hydroxychloroquine Study Brings Scrutiny to Surgisphere". The Scientist. Archived from the original on 3 June 2020. Retrieved 3 June 2020.
Surgisphere is an American healthcare analytics company established in 2008 by Sapan Desai. Originally a textbook marketing company, it came under scrutiny...
Mandeep R. Mehra of the Harvard Medical School and Sapan S. Desai of Surgisphere Corporation, which concluded that the malaria drugs hydroxychloroquine...
from Surgisphere. It was published in The Lancet which retracted it. He co-authored another COVID-19 study that also used suspect data from Surgisphere and...
Desai (born April 6, 1979) is an American physician, and the owner of Surgisphere, originally a textbook marketing company that claimed to provide large...
approval for widely used household and industrial products. The company Surgisphere claimed to have hospital data which was used to support studies of the...
care in Africa. During the COVID-19 pandemic the federation promoted Surgisphere's COVID-19 Severity Scoring Tool for use in 26 African countries. Several...
newspapers expressed suspicions about the validity of the data, provided by Surgisphere, which is founded by one of the authors of the study. The article was...
pandemic. The papers were based on a very large dataset published by Surgisphere, a company owned by Desai. The dataset was exposed as a fabrication,...
Retrieved 27 May 2020. Davey M, Kirchgaessner S, Boseley S (3 June 2020). "Surgisphere: governments and WHO changed Covid-19 policy based on suspect data from...
Archived from the original on 2018-09-15. Covid-19 studies based on flawed Surgisphere data force medical journals to review processes The Guardian, 2020 "MDPI...